Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence
- PMID: 32201353
- PMCID: PMC7156162
- DOI: 10.1016/j.ijantimicag.2020.105948
Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence
Erratum in
-
Erratum to ``A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence'' [International Journal of Antimicrobial Agents 55/6 (2020) 105948].Int J Antimicrob Agents. 2020 Sep;56(3):106137. doi: 10.1016/j.ijantimicag.2020.106137. Epub 2020 Aug 18. Int J Antimicrob Agents. 2020. PMID: 32826129 Free PMC article. No abstract available.
Abstract
COVID-19, the disease caused by SARS-CoV-2, is a highly contagious disease. The World Health Organization has declared the ongoing outbreak to be a global public health emergency. Currently, the research on SARS-CoV-2 is in its primary stages. Based on current published evidence, this review systematically summarizes the epidemiology, clinical characteristics, diagnosis, treatment and prevention of COVID-19. It is hoped that this review will help the public to recognize and deal with SARS-CoV-2, and provide a reference for future studies.
Keywords: COVID-19; Coronavirus; Pneumonia; Respiratory infection; SARS-CoV-2.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Figures
References
-
- World Health Organization . WHO; Geneva: 2020. Coronavirus disease 2019 (COVID-19) Situation Report 40. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
